MX2018001223A - Pharmaceutical composition with improved storage stability and method for preparing the same. - Google Patents

Pharmaceutical composition with improved storage stability and method for preparing the same.

Info

Publication number
MX2018001223A
MX2018001223A MX2018001223A MX2018001223A MX2018001223A MX 2018001223 A MX2018001223 A MX 2018001223A MX 2018001223 A MX2018001223 A MX 2018001223A MX 2018001223 A MX2018001223 A MX 2018001223A MX 2018001223 A MX2018001223 A MX 2018001223A
Authority
MX
Mexico
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Application number
MX2018001223A
Other languages
Spanish (es)
Inventor
Oh Kim Bong
Chan MIN Bum
Yeong KIM Ji
Rim Kim Hye
Hyo Seo Min
Woong Yi Yil
Jin Kyung Kyu
Jeong Yoon Yoo
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of MX2018001223A publication Critical patent/MX2018001223A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition containing a specific related compound in an amount within a specified limit and a method for preparing the same are provided.
MX2018001223A 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same. MX2018001223A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106629 2015-07-28
PCT/KR2016/008270 WO2017018820A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
MX2018001223A true MX2018001223A (en) 2018-11-09

Family

ID=57884713

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001223A MX2018001223A (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same.

Country Status (13)

Country Link
EP (1) EP3328437A4 (en)
JP (1) JP2018521105A (en)
KR (1) KR101787453B1 (en)
CN (1) CN107466231A (en)
AU (1) AU2016299548A1 (en)
BR (1) BR112018001737A2 (en)
CA (1) CA2993928A1 (en)
HK (1) HK1249441A1 (en)
IL (1) IL257187A (en)
MX (1) MX2018001223A (en)
RU (1) RU2018107055A (en)
WO (1) WO2017018820A1 (en)
ZA (1) ZA201801187B (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020507A (en) 1998-03-02 2000-02-01 Bristol-Myers Squibb Company Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile
NZ522442A (en) * 2000-05-12 2004-04-30 Samyang Corp Method for the preparation of polymeric micelle via phase separation of block copolymer
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
MXPA04003621A (en) * 2001-10-18 2004-07-30 Samyang Corp Polymeric micelle composition with improved stability.
WO2005037840A1 (en) 2003-10-16 2005-04-28 Mayne Pharma (Usa), Inc. Method for inverting the c2’ hydroxyl group of taxane esters
KR101024742B1 (en) * 2007-12-31 2011-03-24 주식회사 삼양사 Amphiphilic Block Copolymer Micelle Composition Containing Taxane and Manufacturing Process of The Same
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
WO2009091150A2 (en) * 2007-12-31 2009-07-23 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same

Also Published As

Publication number Publication date
HK1249441A1 (en) 2018-11-02
KR101787453B1 (en) 2017-10-19
BR112018001737A2 (en) 2018-09-11
ZA201801187B (en) 2018-12-19
KR20170015200A (en) 2017-02-08
WO2017018820A1 (en) 2017-02-02
JP2018521105A (en) 2018-08-02
CN107466231A (en) 2017-12-12
CA2993928A1 (en) 2017-02-02
IL257187A (en) 2018-03-29
RU2018107055A (en) 2019-08-28
EP3328437A4 (en) 2019-03-20
EP3328437A1 (en) 2018-06-06
RU2018107055A3 (en) 2019-08-28
AU2016299548A1 (en) 2018-02-22

Similar Documents

Publication Publication Date Title
EP3523419A4 (en) Compositions and methods for maintaining cell viability
MY193806A (en) Affinity-oligonucleotide conjugates and uses thereof
EP3285711A4 (en) Anaerobic blood storage containers
EP3118195A4 (en) Production method for episulfide compound for optical material, episulfide-containing composition, and polymerizable composition including episulfide-containing composition and for use in optical material
IL241046A0 (en) Fertilizer composition and method for preparing the same
EP3130355A4 (en) Pharmaceutical composition containing pregabalin with improved stability and method for preparing same
EP3342414A4 (en) Agent for enhancing atp in cells
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
HK1249129A1 (en) Container for cell administration, storage or culturing
HRP20200104T8 (en) Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
EP3555108A4 (en) Hydrogen storage and delivery material
MX2018001221A (en) Pharmaceutical composition with improved storage stability and method for preparing the same.
MX2018001219A (en) Pharmaceutical composition with improved storage stability and method for preparing the same.
EP3384933C0 (en) Anhydrosugar alcohol composition having enhanced storage stability, and anhydrosugar alcohol storage method
MX2018001222A (en) Pharmaceutical composition with improved storage stability and method for preparing the same.
MX2018001223A (en) Pharmaceutical composition with improved storage stability and method for preparing the same.
AU2016905200A0 (en) Hydrogen storage and delivery material
HK1224131A2 (en) Composition for energy storage, and system thereof
GB2526399B (en) Battery case for lead-acid battery, lead-acid battery using the battery case, and resin composition for the battery case
AU2015901765A0 (en) Improvements in container base